about
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression dataGenome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patientsPrognostic stratification of colorectal cancer patients: current perspectivesHigh serum YKL-40 level after surgery for colorectal carcinoma is related to short survivalMolecular predictors of survival after adjuvant chemotherapy for colon cancerConstruction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancerHigh expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma.Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cellsNew frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsQuantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.Bayesian variable selection with joint modeling of categorical and survival outcomes: an application to individualizing chemotherapy treatment in advanced colorectal cancerThe proteomics of colorectal cancer: identification of a protein signature associated with prognosis.The HER-2/neu oncogene in tumors of the gastrointestinal tract.Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).Recent and ongoing clinical trials for treating colorectal cancer.Prognostic importance of increased cyclooxygenase-2 levels in colorectal carcinomas: a 5-year single-institution studyPrognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.Modern management of colorectal cancer--a pathologist's view.Overexpression of S100A4 is closely associated with progression of colorectal cancer.Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.Development and progression of colorectal neoplasia.Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expressionChromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.Colorectal cancer genomics: evidence for multiple genotypes which influence survivalExpression of P33(ING1b) Protein in Colorectal Cancer.c-erbB-2 is not a major factor in the development of colorectal cancerAn analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.Secretion of N- and O-linked Glycoproteins from 4T1 Murine Mammary Carcinoma CellsPrognostic value of colorectal cancer biomarkers.MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significancePharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review.Immunohistochemical Characterization of Large Intestinal Adenocarcinoma in the Rhesus Macaque (Macaca mulatta).Integrative analysis of the colorectal cancer proteome: potential clinical impact.DNA mismatch repair-dependent response to fluoropyrimidine-generated damage.
P2860
Q24791397-1CEADFEA-F974-4208-B25F-E93FFC09CD5CQ24801499-0CE1109B-DB3F-4CB3-93EC-87F7C5B10929Q26823543-9CCE1C10-D973-42B2-8EE7-841FFC0B9CA7Q28215091-39599418-96B4-4B59-BD5F-A53D981FAE53Q28363159-C9738C06-9BBB-463F-BB46-EAAE0ACB0D75Q31039287-83977580-F902-43BD-812E-3242B0E45958Q33577823-7BD6BDC2-F59E-4A3A-B2D9-84C98068D159Q33648885-9BF9D12B-C46D-49AB-8411-F47BD88A1428Q33731804-4DD6979F-3B73-4228-8E2F-D4F1377B089DQ33834425-FD02933A-D22D-4BD1-8714-1DFD671A5F09Q33852448-0E11A5A4-1834-4DD7-9CC6-962029D5FB04Q34085776-B3953377-0959-4B1E-9937-E4A1ADD5EE73Q34311106-8C9AA931-19D9-40B9-B7D8-A497F1BE567DQ34501563-AA02C2CC-AE87-40E8-975A-083A8680A689Q34660903-B06D9257-E223-4492-95C9-183C366679BBQ34666351-57885D07-075B-4311-BF4D-96F5EFA99F1BQ34733963-6FA70A44-0365-4071-A3BE-A9870E8FCFC2Q35045928-A2293222-FB7F-47E1-801D-964B189CDD71Q35111158-0960231B-ABB9-458E-ABF8-153CF7DA8D12Q35435739-DC7DC1DF-662A-44A4-80F3-8C1BA32B6933Q35586378-8FC69EFA-1C4B-4935-B9B2-4F09A103F487Q35643502-7CDA0F08-5F08-4283-AD54-B49D006AC6C9Q36069009-5E1CE62E-0195-471E-9BD4-2B665EDB8541Q36241935-097B3384-4734-4BFB-8703-DB01F7CBC36CQ36413397-78EBEB47-E006-47C4-BC70-5D3B3895346DQ36612507-71E0CDBF-DEBD-4AF4-9CAD-FD9F532093E0Q36616168-0BA442AE-F348-4F5E-B9B0-7BAD8EC0FF59Q36623125-3E603A54-5721-443C-A72D-C952D371734AQ36636373-FBDCC989-943A-4CB9-80CA-A77482FBC782Q36644043-0DEC22FB-4836-4350-AEC6-6B1399EC6212Q36644150-C53FC21E-C7DA-4221-AE8E-DCC3F350DAFFQ36734636-D2655340-23B6-490F-9B55-C76B386FA342Q36934474-01169985-E440-40EF-990F-C83214737EA9Q37132721-27737194-E8AE-4E9F-916E-33CDB3D88599Q37222803-FB552F99-02E3-4D85-9E66-9AB0A786ABF9Q37346216-C379CCFF-14BB-4A3D-92CB-D8A7A88B8BC4Q38181431-D1C9BA37-9FED-4435-809B-FA6C8281EDE2Q38264789-8384AF21-F3FF-4B47-9A42-828CE75DE86CQ38947015-ACC0AF97-1F9C-4A3E-B3D3-1C8AF32F225CQ40478691-5FEB3C67-A44B-4D15-8443-18EFD9FBCF33
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Tumour markers of prognosis in colorectal cancer.
@ast
Tumour markers of prognosis in colorectal cancer.
@en
type
label
Tumour markers of prognosis in colorectal cancer.
@ast
Tumour markers of prognosis in colorectal cancer.
@en
prefLabel
Tumour markers of prognosis in colorectal cancer.
@ast
Tumour markers of prognosis in colorectal cancer.
@en
P2860
P356
P1476
Tumour markers of prognosis in colorectal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690033
P407
P577
1999-01-01T00:00:00Z